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This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).SUMMARYWe describe the use of a characteristic blue fluorescence to identify and isolate pluripotent human embryonic stem cells and human-
induced pluripotent stem cells. The blue fluorescence emission (450–500 nm) is readily observed by fluorescence microscopy and
correlates with the expression of pluripotency markers (OCT4, SOX2, and NANOG). It allows easy identification and isolation of undif-
ferentiated human pluripotent stem cells, high-throughput fluorescence sorting and subsequent propagation. The fluorescence appears
early during somatic reprogramming. We show that the blue fluorescence arises from the sequestration of retinyl esters in cytoplasmic
lipid bodies. The retinoid-sequestering lipid bodies are specific to human andmouse pluripotent stem cells of the primed or epiblast-like
state and absent in naive mouse embryonic stem cells. Retinol, present in widely used stem cell culture media, is sequestered as retinyl
ester specifically by primed pluripotent cells and also can induce the formation of these lipid bodies.INTRODUCTION
Human pluripotent stem cells (HPSCs) are a valuable
resource to model disease and early development. Due to
differentiation, it is a challenge to retain pluripotency dur-
ing their culture and expansion. Methods currently used to
isolate HPSCs have inherent experimental variability and
efficiency, and are (1) mechanical isolation based on
morphology (Maherali et al., 2007; Meng et al., 2011)
that requires experience, and is laborious and not efficient;
(2) quantification of the endogenous expression of stem
cell transcription factors (OCT4, SOX2, etc.) (Gerrard
et al., 2005; Wernig et al., 2007; Zhang et al., 2011) in live
cells, which requires genome modification; (3) fluores-
cence-activated cell sorting (FACS)-based analysis using
cell surface markers (SSEA-4, TRA-1-60, etc.) (Li et al.,
2010; Lowry et al., 2008), which requires use of antibody-
based staining that is inherently variable; and (4) more
recently, a pluripotent stem cell-specific adhesion signature
(Singh et al., 2013), which is dependent on the surface
properties of cell clusters and thus interrogates the popula-
tion and not individual cells.
A large number of endogenous fluorophores are present
within cells [e.g., NAD(P)H, FADH, cytochromes, etc.]
(Stringari et al., 2012) and some studies have used these flu-
orophores and their fluorescence lifetimes to establish their
differentiation (Stringari et al., 2012) and viability status
(Buschke et al., 2011). However, these studies failed to
establish an association with any unique fluorophore or
isolate individual HPSCs. The studies also did not associateStethe fluorescence with any specific developmental stage or
follow it through the process of reprogramming.
In this report, we demonstrate that pluripotent stem cells
of the epiblast-like/primed state exhibit a characteristic
blue fluorescence in standard media that arises from the
sequestration of retinyl esters in cytoplasmic lipid bodies.
The fluorescence is easily detected usingwide field epifluor-
escencemicroscopy. It allows for efficient single cell separa-
tion using FACS and propagation. The fluorescence also
serves as an early reprogramming marker for induced
human pluripotent stem cells (HiPSCs). Finally, we show
that whereas mouse embryonic stem cells (ESCs) do not
have fluorescent lipid bodies, they are present in pluripo-
tent mouse epiblast-like cells (mEpiSCs) and in the epiblast
region of the mouse embryo.RESULTS
Human Pluripotent Stem Cells Have Characteristic
Blue Fluorescent Cytoplasmic Lipid Bodies
HPSC cultures on mouse embryonic fibroblast (MEF)
feeders in standardmediawith serumor serum replacement
exhibited a blue fluorescence easily observed by epifluores-
cence microscopy (excitation 325–375 nm, emission 450–
500 nm) and readily capturedwith a cooled charge-coupled
device camera (Figure 1A). The blue fluorescencewas associ-
ated with most cells within colonies with typical human
ESC (HuESC) colony morphology, although individual
cells had varied levels of fluorescence (Figure 1A). At highm Cell Reports j Vol. 3 j 169–184 j July 8, 2014 j ª2014 The Authors 169
Figure 1. Human Pluripotent Stem Cells
Have Cytoplasmic Lipid Bodies that
Exhibit Characteristic Blue Fluorescence
(A) Blue fluorescence (excitation, 325–
375 nm; emission, 460–500 nm) was
observed in HPSC (HuESC and HiPS; i.e.,
NFF_iPS, ADF_iPS, and LCL_iPS) colonies
cultured in standard media and culture
conditions.
(B) Representative high-magnification
confocal image of HuES7 cells showing blue
fluorescence confined to spherical bodies.
(C) The fluorescent spherical bodies often
show polarized distribution within cells
(red arrows, upper row) and stain positive
for lipid body-specific markers (BODIPY and
Nile red; middle row). The merged images of
BODIPY-blue fluorescence and Nile red-blue
fluorescence are shown in the lower row.
BF, bright field; NFF, neonatal foreskin
fibroblast; ADF, adult dermal fibroblast;
LCL, lymphoblastoid cell line. See also
Figure S1.
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multiple spherical cytoplasmic bodies that were 0.5–1 mm
(Figure 1B) and often perinuclear (Figure 1C, red arrows).
The fluorescence was retained on fixation with paraformal-
dehyde and prone to bleaching but recovered in live cells
(Figure 1C). The fluorescence is unlikely to be autofluores-
cence from dying cells because we do not see any autofluor-
escence at green or red wavelengths (Figure S1C available
online). These bodies were stained with lipid body-specific
markers BODIPYandNile red (Figure 1C) andwere not asso-
ciated with other cytoplasmic compartments (Figure S1D).
Human neonatal foreskin fibroblasts (NFF), MEFs, mesen-
chymal stem cells, and HPSC-derived neurons had much
lower blue fluorescence (Figures S1A and S1B).
Blue Fluorescent Lipid Bodies Are Associated with
Markers of Human Pluripotent Stem Cells
HPSC colonies often show signs of differentiation in cul-
ture apparent as regions of altered morphology. Pluripo-
tency markers such as OCT4, SOX2, and NANOG can be
used to determine the differentiation status of HPSCs but
these require cells to be fixed and immunostained or engi-
neered to report their expression (Takahashi and Yama-
naka, 2006). Cells in HPSC cultures, which stained positive
for pluripotency markers, also had highly correlated blue170 Stem Cell Reports j Vol. 3 j 169–184 j July 8, 2014 j ª2014 The Authorsfluorescence (Figure 2A). In colonies, wherever the cells
looked differentiated, the fluorescent lipid bodies had
either disappeared (Figure 2B) or had decreased (Figure 2C)
with a corresponding absence/decrease in the levels of
OCT4, SOX2, and NANOG. Mean fluorescence intensity
values from cells having both blue fluorescence and plurip-
otencymarkers resulted in a tight linear fit: OCT4 (R2 = 0.9),
SOX2 (R2 = 0.9), and NANOG (R2 = 0.83; Figure 2A).
Blue Fluorescence Can Be Used to Sort and Enrich for
Human Pluripotent Stem Cells
Because individual HuES7 cells exhibit variable levels of
blue fluorescence, we examined its relationship to pluripo-
tency and its utility to isolate undifferentiated cells from
differentiating cells by FACS. HuES7 cultures resolved
into two distinct populations on sorting using blue fluores-
cence (DAPI channel). The peak fluorescence intensities of
the two populations labeled as high blue and low blue
differed approximately 100-fold (Figure 3A). The fluores-
cence intensity of the high-blue population was approxi-
mately equal to the fluorescent intensity of the cells stained
with 50 ng/ml of Hoechst stain (Figure S2A). A proportion
of cells within the high-blue peak was strongly associated
with the pluripotent state of the cultures. Largely undiffer-
entiated cultures were characterized by lower peak heights
Figure 2. Blue Fluorescence from Lipid Bodies Is Associated with Pluripotent Stem Cells and Aids in Easy Identification of
Differentiated Cells from Pluripotent Stem Cells during Routine Culture
(A) Cells that express pluripotency markers (OCT4, NANOG, and SOX2) have blue fluorescent lipid bodies. Mean fluorescence intensities of
blue fluorescence correlate positively with the fluorescence intensities of pluripotency markers.
(B) HPSCs differentiated by removing bFGF show absence of lipid body-associated blue fluorescence and pluripotency markers. Differ-
entiated regions (marked with red dotted lines) are identified by cellular morphology. The correlation between blue fluorescence and
pluripotency markers in differentiating cultures is not evident (red arrow).
(C) Dual antibody staining (SOX2 and OCT4) of HPSC cultures are in accordance with Figures 2A and 2B above. Fluorescence intensities of
equisized ROIs encompassing 10–15 cells across several images were measured to obtain scatter plots.
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high-blue population,whereasmore differentiated cultures
(i.e., culturedwithout basic fibroblast growth factor [bFGF])
had the reverse profile (Figure 3A). Equal numbers of cells
(n = 30,000) from the high-blue region, the low-blue
region, and from an unsorted population on mitotically
inactivated MEFs in standard media without ROCK
inhibitor (ROCKi) were plated. In undifferentiated cul-
tures, the high-blue cell populations always gave rise to
larger numbers of colonies with the typical HuES-like
morphology compared to the unsorted and low-blue popu-
lations (Figure 3B; Figure S2C). In differentiating cultures,
sorting for blue fluorescence helped to recover more cells/Stecolonies than unsorted cells, suggesting that sorting for
blue fluorescence is beneficial (Figure 3B). To rule out cell
death in the low-blue population after sorting, propidium
iodide (PI)-negative low-blue cells were plated and imaged
after 4 days. The majority of cells acquired a flattened
morphology and stained positive for active mitochondria
with unfragmented nuclei (Figure S2D), indicating that
cells with low-blue fluorescence remained alive and repre-
sent the differentiating fraction of cells. The relative pro-
portion of high-blue and low-blue cells in the PI-negative
population of cells from multiple undifferentiated and
differentiating cultures was determined and was in
agreement with the above FACS profiles (Figure 3C). Them Cell Reports j Vol. 3 j 169–184 j July 8, 2014 j ª2014 The Authors 171
(legend on next page)
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Retinoid Fluorescence in Pluripotent Stem Cellspluripotent nature of the sorted cells was also established
with FACS analysis with dual staining of pluripotency
markers and blue fluorescence. A high degree of correlation
was observed between all the pluripotency markers exam-
ined and blue fluorescence (Figure 3D; Figure S2B). In cul-
tures without bFGF, the cells differentiated along with a
concomitant decrease in blue fluorescence levels and plu-
ripotency marker levels (Figure 3E; Figure S2B). Repeated
sorting/propagation of HuES7 colonies did not alter the
blue fluorescence profile, suggesting that sorted cells
continue to behave like regular HuES7 cells with some dif-
ferentiation always observed (represented by cells within
the low-blue region; Figure 3F). Furthermore, the high-
blue sorted cells were functionally pluripotent whereas
cell aggregates of the low-blue population failed to form
embryoid bodies (EBs; Figure 3G).
Propagation ofHPSC cultures from single cells is reported
to be inefficient and dissociation to single cells leads to very
low survival (Li et al., 2009). FACS necessitates the dissoci-
ation of colonies into single cells prior to sorting. Our re-
sults after sorting by blue fluorescence indicate that it is
possible to propagate HPSCs after dissociating them into
single cells without the use of ROCKi.
In general, HPSC cultures with large percentages of differ-
entiating cells are not known to survive multiple passages.
To determine whether such cultures can be rescued, we
sorted differentiating HuES cultures and plated the cells
with high-blue fluorescence onto MEF feeders. Pluripotent
colonies with typical morphology were obtained by day 7
(Figure S2E).
These results indicate that (1) levels of lipid body-associ-
ated blue fluorescence correlated positively with pluripo-
tency and self-renewal, and (2) high-speed sorting of single
cells for blue fluorescence facilitated the isolation of large
numbers of pluripotent stem cells away from differentiated
cells. Therefore, sorting by blue fluorescence presents sig-
nificant advantages over existing protocols of isolating
and propagating human pluripotent stem cells.Figure 3. Lipid Body-Associated Blue Fluorescence Can Be Used t
(A) Pluripotent stem cells from HPSC cultures when dissociated into s
populations. In an undifferentiated culture, the two populations sho
tinguishing the undifferentiated cells from their differentiated count
becomes heterogeneous with lower number of cells under the high b
(B) Colony counts from high blue region, low blue region, and unsor
(C) Normalized (viable) cell counts from high blue and low blue regio
(D and E) FACS analysis of blue fluorescence levels in undifferentiated a
markers.
(F) Repeated sorting/propagation of HPSC colonies (by FACS) did no
(G) Typical embryoid body and cell aggregate generated from high bl
Qualitative RT-PCR analysis of EBs from unsorted and high blue popu
Data are from three independent biological replicates; error bars indica
EBs from unsorted population. The agarose gel images are obtained f
SteHuman Somatic Cells Acquire Blue Fluorescent Lipid
Bodies Very Early during Reprogramming
Lipid bodies with blue fluorescence are present in both
HuESC and HiPSC colonies (Figure 1A) and are far fewer
and not fluorescent in human somatic cells (Figure S1A).
We monitored the appearance of fluorescent lipid bodies
in somatic cells that were being reprogrammed to become
pluripotent. Cells from different somatic tissues—i.e., hu-
man neonatal fibroblasts and EBV-transformed adult lym-
phoblastoid cell lines (LCLs)—were reprogrammed using
themethod of Okita et al. (2011). As early as 7–10 days after
transfection, clusters of cells with altered morphology ex-
hibited blue fluorescence while the surrounding MEF layer
(used for LCL_iPSC generation) and somatic cells did not
(Figures 4A and 4B; Figure S3A). These cell clusters gave
rise to typical HiPSC colonies by appearance (Figures 4A
and 4B; Figure S3A). All of the blue fluorescent clusters
that were examined stained for SSEA-4 (Figure S3A). A total
of 30 random cell clusters were monitored from six
different experiments and by 20 days, 27 of these clusters
became colonies with typical HiPSC morphology (Fig-
ure S3B). A total of six colonies (one per experiment)
were expanded and all were positive for the pluripotency
markers tested (Figure S3C). This establishes that blue fluo-
rescence can be used to monitor reprogramming. We also
characterized an NFF_iPSC (NFF-derived iPSCs) and an
LCL_iPSC (LCL-derived iPSCs) used in this study for differ-
entiation (Figures S3D and S3E).
Furthermore, the blue fluorescence distribution profiles
of the HiPSCs were similar to those of HuES7 cells and
were always higher (nearly 100-fold) than their somatic
precursors (Figure 4C). The lower level blue fluorescence
seen in somatic cells as a single FACS peak could be
from NAD(P)H and other intrinsic fluorophores (Ander-
sson et al., 1998; Buschke et al., 2012). These results indi-
cate that the blue fluorescence associated with lipid bodies
can serve as a reprogramming marker and aid in the identi-
fication of cells being reprogrammed.o Sort and Propagate Pluripotent HPSCs
ingle cells and sorted by blue fluorescence resolve into two distinct
w a significant difference in their levels of blue fluorescence, dis-
erparts. In differentiating cultures, the high blue region broadens,
lue peak.
ted cells from undifferentiated and differentiating cultures.
ns of undifferentiated and differentiating cultures.
nd differentiating cultures along with dual staining of pluripotency
t alter the blue fluorescence profile of HPSC cultures.
ue and low blue populations from sorted HuES7 cells, respectively.
lations of HuES7 to establish functional pluripotency.
te the SD. **p < 0.01. EB-HB, EBs from high blue population; EB-UN,
rom different lanes of a single gel. See also Figure S2.
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Retinoid Fluorescence in Pluripotent Stem CellsBlue Fluorescent Lipid Bodies Are Absent in Mouse
Inner Cell Mass but Present in Mouse Epiblast and in
mEpiSC-like Cells
Mouse ESC (mESC) colonies grown in 20% KnockOut
Serum Replacement (KOSR) ESC media had very faint
blue fluorescence compared to that in HPSC colonies (Fig-
ures 5A and 5B). Higher magnification images of BODIPY-
stainedmESCs showed very few lipid bodies (white arrows)
that were almost always at the colony edge, and did not
show blue fluorescence (Figure 5C). The faint blue fluores-
cence observed in mESCs colocalized with the mitochon-
dria-specific dye TMRM (R2 = 0.93). The inset with blue
fluorescence (brightness-enhanced) allows better visualiza-
tion (Figure 5D). This was unlike human pluripotent cells
in which the blue fluorescence was localized to the lipid
bodies (Figure 5C; Figure S1D). FACS analysis of mESCs
showed a single population with low-blue fluorescence
whereas HuESCs had a characteristic bimodal distribution
(Figure 5E). These results suggest that the blue fluorescence
observed in mESCs and HPSCs emanated from different
cellular compartments and cells.
Mouse pluripotent stem cells are believed to represent a
naive state whereas the human pluripotent stem cells
represent a slightly later developmental stage termed as
the primed or epiblast-like state (Zhou et al., 2012). To
determine whether the blue fluorescent lipid bodies
were also present in vivo and specifically mark the primed
or epiblast-like cells, we examined mouse embryos at
3.5 days postcoitum (dpc) to evaluate the mouse inner
cell mass and at 6.5 dpc, the developmental stage from
which mouse epiblast stem cells (mEpiSCs) are derived
(Brons et al., 2007; Chenoweth and Tesar, 2010; Najm
et al., 2011). Confocal images of 3.5 dpc embryos showed
very few BODIPY-stained lipid bodies that were not fluores-
cent in the blue region and did not localize to the inner cell
mass (Figure 5F). The distal epiblast region of the 6.5 dpc
embryo had blue fluorescent puncta that were also stained
by BODIPY (Figure 5G).
We dissociated and plated 6.5 dpc mouse embryos in
EpiSC-specific media (KOSR 15% and FBS 5% with bFGF)
(Najm et al., 2011) and propagated the epiblast-like colony
outgrowths by mechanical dissociation. The colonies re-
tained fluorescent lipid bodies (Figure 5H). Comparison
of mean fluorescence intensities of blue fluorescence with
BODIPY fluorescence in both the postimplanted mouse
embryo (6.5 dpc) and the mEpiSC-like colonies showed aFigure 4. Fluorescent Lipid Bodies Appear Early in the Reprogram
(A and B) Neonatal foreskin fibroblasts (NFF) and lymphoblastoid ce
bodies during reprogramming [D(n), days posttransfection and platin
(C) The blue fluorescence FACS profiles of human induced pluripotent
closely with those of human embryonic stem cells (HuES7).
See also Figure S3.
Stetight correlation (Figures 5I and 5J; n = 3 independent ex-
periments). These results suggest that blue fluorescent lipid
bodies are characteristic of the epiblast-like state and differ-
entiate them from the naive stem cells. To our knowledge,
there are no known specific markers for the epiblast stem
cells in vivo and the lipid body-associated blue fluorescence
may serve as a useful marker in vivo and in vitro.
Blue Fluorescent Lipid Bodies Are Associated with the
Primed State of Pluripotent Stem Cells
We then explored the association of fluorescent blue lipid
bodies with stem cells from primed and naive states.
When HuES7 cells were cultured in media that promotes
their conversion to the naive state (Hanna et al., 2010), it
resulted in a significant decrease in blue fluorescence along
with a corresponding decrease in the number of lipid
bodies in 48 hr (Figure 6A, top and second rows). FACS
analysis of HuES7 cells (PI negative) in conversion media
confirmed the decrease in blue fluorescence (Figure 6B).
The cells in the conversion media had smaller nuclei and
were more compact in naive cells (Figure 6A, third row).
Levels of SSEA-4, a specific marker of primed cells, showed
a significant decrease in the conversion media (Figure 6A,
bottom row). Transcript levels of FGF-5, a marker for
primed cells, also decreased as shown with RT-PCR analysis
(Figure 6C).
mES-D3 cells were cultured inmedia that helps their con-
version to the primed state (Takehara et al., 2012). In this
media, the mES-D3 cells acquired blue fluorescent lipid
bodies, strengthening the association of an epiblast-like
state with these organelles (Figure 6D). FACS analysis of
the mES-D3 cells (PI negative) also confirmed the appear-
ance of blue fluorescence (Figure 6E). The ES-D3 cells also
acquired larger nuclei, similar to primed cells (Figure 6D,
bottom row).
The Blue Fluorescence Arises from Retinyl Esters
Sequestered in Cytoplasmic Lipid Bodies
Lipid bodies were isolated from HuES7 cells through differ-
ential sucrose gradient centrifugation (Bulankina, 2003).
They were fluorescent and the fluorescence partitioned
into chloroform: methanol (CHCl3:MeOH at 3:1; Fig-
ure 7A), suggesting the fluorophore to be hydrophobic.
TheCHCl3:MeOH extract had absorbance and fluorescence
characteristics, i.e., excitation and emission profiles very
similar to retinoids (retinol or retinyl esters such as retinylming of Somatic Cells
ll lines (LCL) show very early appearance of blue fluorescent lipid
g]. The background MEF feeder layer remains nonfluorescent.
stem cells HiPSCs (NFF-iPSCs and LCL-iPSCs) are similar and match
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Figure 5. Blue Fluorescent Lipid Bodies Are Absent in Naive Mouse Pluripotent Stem Cells and Mouse Blastocyst Inner Cell Mass
but Present in Cells in Postimplantation Mouse Epiblast Cells and mEpiSC-like Cells
(A and B) Representative phase contrast and fluorescence images (low and high magnification) of mES-D3 and HuES7 colonies. mES-D3
cells have far lower blue fluorescence compared to HuES7 cells (fluorescence intensity normalized to HuES7 cells).
(C) BODIPY stained and blue fluorescence high-magnification images of mES-D3 and HuES7. mESCs show occasional lipid bodies (white
arrows), which are not fluorescent unlike HuESCs.
(legend continued on next page)
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Retinoid Fluorescence in Pluripotent Stem Cellspalmitate or retinyl oleate) (Morton et al., 1930). The fluo-
rescence spectra of the CHCl3:MeOH extract and retinyl
palmitate were identical (Figure 7B). The components of
the CHCl3:MeOH extract were resolved with reverse-phase
high-performance liquid chromatography (HPLC) and
compared with retinoid standards (retinyl palmitate,
retinol, and retinyl acetate) by absorbance. The retention
time of the primary/main peak of the CHCl3:MeOH extract
coincided with that of retinyl palmitate at 18.65 min and
was substantially different from retinol and retinyl acetate
(6.65 and 7.33 min, respectively; Figure 7C). Because all
the fluorescence observed in the CHCl3:MeOH extract
(Figure 7B) could be accounted for and was identical to
the retinyl palmitate fluorescence, we conclude that the
fluorescence emanating from the lipid bodies was largely
from retinyl palmitate or a retinoid very similar to it,
perhaps retinyl oleate.
Animal cells are unable to synthesize vitamin A. In cul-
ture, it is available from serum in the media as retinol,
which is taken up by cells and converted to retinyl esters
(palmitate or oleate) or oxidized to retinal and retinoic
acid (van Berkel, 2009; Guo et al., 2000). We tested for
retinol in standard HuES media that contained KOSR,
ESC-certified serum, and a commercially available serum-
free media ReproFF2 (ReproCell). Samples were extracted
with CHCl3:MeOH and resolved with reverse-phase
HPLC. All samples contained retinol that matched the
retinol standard at 6.65 min (Figure 7D).
We also determined that HPSCs take up retinyl esters
from the media, and the blue fluorescence correlated with
retinyl ester levels. Cells grown onMEFs in standard media
with 20% KOSR, supplemented with retinol or retinyl
palmitate at various concentrations (0.5–10 mM), showed
a dose-dependent increase in the blue fluorescence of their
lipid bodies after 48 hr (Figure 7E).
mES-D3 and R1 cells showed no significant increase in
retinoid-associated fluorescence even after 48 hr in mESC
media supplemented with 10 mM retinol or retinyl palmi-
tate (Figures S4A and S4B), whereas HuES7 cells had a
substantial increase under identical conditions (Figure 7E;
Figure S4C). On incubation for 72 hrwith retinyl palmitate,(D) A faint blue fluorescence is observed in mES-D3 cells. When the
chondria-specific dye, TMRM (inset), in mES-D3 cells.
(E) mESCs exhibit lower and unimodal blue fluorescence distribution
(F) Blue fluorescent lipid bodies are absent in the inner cell mass of
(G) The epiblast region (from a 6.5 dpc mouse embryo) shows numer
(H) Mouse epiblast-like stem cells (mEpiSC) cultured from mouse emb
(p1, p2, and p3) retain blue fluorescent BODIPY-positive lipid bodies.
and colocalization of blue fluorescence with BODIPY.
(I and J) Scatter plots of BODIPY mean fluorescence intensities versus
embryo (6.5 dpc) and in mEpiSC-like cells cultured in vitro show hig
equally sized ROIs encompassing 10–15 cells across several images w
StemESCs exhibited a slight increase in blue fluorescence.
Although retinol caused an increase in blue fluorescence
in mESCs, it remained substantially lower than the blue
fluorescence observed in HuESCs (Figure S4D).
Essential 8 (E8) media is a recently available, chemically
defined serum-free media for HPSC cultures with minimal
components and does not contain vitamin A (Chen et al.,
2011). HuES7 cells cultured in E8 media showed a rapid
decrease in lipid bodies along with its associated fluores-
cence in 24 hr, and the lipid bodies disappeared in 72 hr
(Figure 7F). The addition of retinol (10 mM) to these cultures
resulted in the reappearance of fluorescent lipid bodies
(Figure 7F). Together with previously described results,
this suggests that primed pluripotent stem cells can take
up retinoids and that retinol can induce lipid bodies that
sequester it as retinyl esters.DISCUSSION
HPSCs under culture conditions with serum or serum re-
placements, such as KOSR, have large numbers of small
blue fluorescent lipid bodies. These are strongly associated
with pluripotency markers (i.e., OCT4, SOX2, NANOG,
SSEA-4, and TRA-1-60) and allow for the identification
and isolation of pluripotent stem cells. On sorting, HPSCs
resolve into two populations with a near 100-fold differ-
ence between their peak blue fluorescence. Only the cells
with high-blue fluorescence are pluripotent and give stem
cell colonies. The separation of the two populations is
easy, efficient, and lends to high-throughput single cell
analysis and propagation. Repeated sorting and propaga-
tion does not alter the fluorescence profiles and the sorted
cells remain as regular HPSCs. The fluorescent lipid bodies
also appear early during the reprogramming of somatic
cells. This allows for easy detection and isolation of cells
being reprogrammed and could help in the identification
and interrogation of the early steps in the reprogramming
process.
A recent elegant method used fluorescence lifetimes to
distinguish lipid body fluorescence from that of NAD(P)fluorescence intensity is maximized, it colocalizes with the mito-
whereas HuESCs exhibit a bimodal distribution.
the 3.5 dpc mouse embryo.
ous blue fluorescent puncta that stain positive with BODIPY.
ryo (6.5 dpc) in mEpiSC media (K15F5) and sequentially passaged
The lower image shows cells from a p3 culture at high magnification
mean blue fluorescence intensities in the postimplantation mouse
h positive correlation. BF, bright field. Fluorescence intensities of
ere measured to obtain scatter plots.
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Figure 6. Blue Fluorescent Lipid Bodies Are Associated with the Primed State of Pluripotent Stem Cells
(A) Comparison of HuES7 cells grown in standard media (human primed) and in conversion media (human naive) shows decrease in blue
fluorescent lipid bodies when grown in conversion media (first and second rows). The nuclear size is altered (third row) and levels of SSEA-4
(a specific marker for primed epiblast cells) decrease (bottom row) when grown in conversion media.
(B) FACS analysis of HuES7 cells grown in conversion media shows a decrease in blue fluorescence levels.
(C) Cells grown in conversion media show a decrease in FGF-5 (specific marker for epiblast cells) transcript levels compared to those in
standard media.
(D) mES-D3 cells show an increase in blue fluorescent lipid bodies when grown in conversion media (mouse primed; first and second rows).
Cells grown in conversion media also show the expected increase in nuclear size.
(E) FACS analysis of mES-D3 cells grown in conversion media shows an increase in blue fluorescence levels.
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Retinoid Fluorescence in Pluripotent Stem CellsH and used their relative ratio to identify pluripotent
HuESCs (Stringari et al., 2012). The authors hypothesized
that the lipid body fluorescence originated due to ROS-
induced lipid peroxide-protein reactions and that stem
cells have high ROS levels. We and other groups observe
that human pluripotent stem cells have low ROS levels
(Haneline, 2008; Pervaiz et al., 2009; Shi et al., 2012;
Wang et al., 2013). Our method is based on total blue fluo-
rescence levels determined with fluorescence microscopy178 Stem Cell Reports j Vol. 3 j 169–184 j July 8, 2014 j ª2014 The Authorsor FACS and allows isolation and propagation. We show
that the fluorescence emanates from retinyl esters, such
as retinyl palmitate in lipid bodies from extracellular
retinol that is taken up and esterified. LRAT, which con-
verts retinol to its ester, is expressed in human pluripotent
cells. Increasing external retinol or retinyl palmitate causes
a dose-dependent increase in the fluorescence of the lipid
bodies. The sequestration of retinol as esters in lipid bodies
may be for storage and later use as retinoic acid. Retinyl
Stem Cell Reports
Retinoid Fluorescence in Pluripotent Stem Cellsesters in lipid bodies would resist oxidation to retinoic
acid, a powerful differentiation signal for pluripotent
stem cells. The storage of retinyl esters is analogous to
the sequestration of histones in lipid bodies in Drosophila
embryos (Li et al., 2012).
Retinoids (vitamin A) are important for a number of
physiological and developmental processes including
reproduction. Retinoic acid, one of the retinoids, plays an
essential role in early development and maintenance of
specific tissue types. Khillan and colleagues demonstrated
that retinol can be used tomaintainmESCs in a pluripotent
state in feeder-free cultures (Chen et al., 2007). Retinol
increases the expression of NANOG and promotes self-
renewal by activating PI3K/AKT and the IGF-1/IRS-1
pathway (Chen and Khillan, 2010; Chen et al., 2007).
Wang et al. (2011) showed that retinoic acid receptor
gamma, liver receptor homolog 1, and retinoic acid analogs
promote faster reprogramming of mouse and human
somatic cells. Vaajasaari (2009) and Rajala et al. (2011)
have also reported that retinol increases the expression of
OCT4 and NANOG in HuESCs. These results show that
retinol and some of its nonoxidized derivatives can have
a significant role in the self-renewal of pluripotent stem
cells.
mESCs in media with serum or serum-replacements
have very few lipid bodies and low levels of blue fluores-
cence. mESCs do not take up retinol or retinyl palmitate
at levels seen in primed cells, although the retinol typi-
cally present at 200 nM or less is actively sequestered
by HPSCs. Prolonged incubation of mESCs with retinyl
palmitate did not increase blue fluorescence, whereas
retinol caused a slight increase. Examination of available
transcriptomes of mouse and HuESCs indicate significant
differences in transcripts related to retinol uptake and
metabolism. RBP, STRA6, LRAT that encode proteins
that bind, transport, and convert retinol to its ester,
are expressed many fold more in human pluripotent cells
than in mESCs (http://amazonia.transcriptome.eu, U133A
[Enver et al., 2005]; NCBI GEO accession number
GSM87830, MoES.C57B). STRA6 is a G protein-coupled re-
ceptor and suggested to induce lipogenesis when activated
by retinol (Muenzner et al., 2013). This may explain the
presence of fluorescent lipid bodies only in epiblast-like
or primed pluripotent human cells, and why HuESCs in
E8 media lack lipid bodies and when supplemented with
retinol acquire them. STRA6 mutations in humans also
have varied and strong phenotypes (Chassaing et al.,
2009). Retinol could play a significant role in pluripotency
and it may be useful to have retinol/retinyl esters in the
media.
We considered the possibility that lipid bodies are only
present in primed or epiblast-like cells. Examination of pre-
implantation (3.5 dpc) and postimplantation (6.5 dpc)Stemouse embryos showed the presence of blue fluorescent
lipid bodies only in the latter. Retinol/retinoic acid are
involved at this developmental stage (Huang et al., 2001).
Mouse epiblast-like stem cells derived from postimplanta-
tion embryos also led to colonies similar to HuESC
colonies, with fluorescent lipid bodies. In media that shift
human pluripotent stem cells to the naive state or mESCs
to the primed state, the cells show the appropriate shift
in blue fluorescent lipid bodies. These results suggest lipid
bodies that sequester retinoids to mark the epiblast-like
state provide opportunities to explore their functional
roles and can distinguish naive from primed pluripotent
stem cells. Lipid bodies are also associated with specific
metabolic states, and may mark a primed metabolic
state because changing the media dramatically alters their
levels.
The role of lipid bodies, in cellular physiology and devel-
opment, is becoming increasingly evident. It may have a
role to play in primed pluripotent cells. In most somatic
cells, lipid bodies, usually present in small numbers, are
heterogeneous in composition within and between cell
types (Ducharme and Bickel, 2008; Li et al., 2012; Walther
and Farese, 2012). They consist of mostly neutral lipids
associated with specific proteins that vary between cell
types. Cells with lipid bodies that sequester retinyl esters
are uncommon. Retinal pigmented epithelium and hepatic
stellate cells are two examples. Lipid bodies are also sites of
lipogenesis, lipid storage, and synthesis of lipid signaling
molecules, such as arachadonic acid, which has been impli-
cated in the maintenance of pluripotency. Recent studies
have implicated retinol to activate the JAK/STAT pathway
and to regulate lipid accumulation via SOCS3 and PPARg
(Berry and Noy, 2012; Berry et al., 2012). Electron
micrographs of primate pluripotent stem cells portray
structures that could be lipid bodies but were assumed to
be lysosomes or glycogen granules (Johkura et al., 2004).
Lipid bodies, although reported in primate pluripotent
stem cells, were not associated with epiblast stem cells
(Cibelli et al., 2002; Stringari et al., 2012). Oleate, a lipid,
has also been related to pluripotency (Ben-David et al.,
2013). E8 media does not contain any lipid or retinoids
and HPSCs in E8 remain pluripotent, so retinoids are not
essential for pluripotency. The lipids necessary for cell
growth are synthesized endogenously. HPSCs grown in
E8 with retinol acquire lipid bodies in 24–48 hr, indicating
their ability to acquire these bodies. It is currently not clear
what advantages retinol provides in the propagation of
pluripotent stem cells other than the increased expression
of NANOG and OCT4 in HuESCs (Rajala et al., 2011).
In conclusion, we have identified retinyl ester-contain-
ing lipid bodies to be associated with primed or epiblast-
like pluripotent stem cells. The fluorescent lipid bodies
can be easily used for routine identification, isolation,m Cell Reports j Vol. 3 j 169–184 j July 8, 2014 j ª2014 The Authors 179
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Retinoid Fluorescence in Pluripotent Stem Cellsand propagation of primed pluripotent stem cells. They are
early markers of reprogramming cells in standard media
and possibly inmedia such as E8, in the presence of retinol
or its esters. In addition, the processes that underlie this
striking difference between naive and epiblast-like stem
cells should help us understand the mechanisms involved
in pluripotency and pluripotent states.EXPERIMENTAL PROCEDURES
FACS and Colony Evaluation
Flow cytometry and sorting were performed using 2–2.5 million
cells/ml. The colonies were enzymatically dissociated with ESGRO
Complete Accutase (EMD Millipore; SF006) and resuspended in
KO-DMEM (Life Technologies; 10829-018), 100 mM 2-mercaptoe-
thanol (Life Technologies; 21985-023), 10 nM nonessential amino
acids (Life Technologies; 11140-050), 100 mM L-glutamine (Life
Technologies; 35050061), 0.5% fetal bovine serum (Life Technolo-
gies; 10270), and 5 ng/ml recombinant human bFGF (Peprotech;
00-18B) and sorted using a BD FACSAria II special order system
(BD Biosciences) in the presence of 1 mg/ml PI (Sigma-Aldrich;
P4864). Only live cells (PI negative) were analyzed and separated
using a 375 nm near-UV laser and a Trigon detector with a 450/
50 nm bandpass filter (DAPI channel) to detect the blue fluores-
cence signal. The PMTvoltagewas set at 350V, and 30,000 live cells
from the high-blue, low-blue, and unsorted populations treated
in the same way as the sorted populations were plated on MEF
feeder layers conditioned with HuESC media. On day 5, colonies
were counted and morphologies of the colonies evaluated in
three independent experiments. Data analysis was performed us-
ing Cyflogic 1.2.1, (http://www.cyflogic.com) and FlowJo (http://
www.flowjo.com). Use of cells fromanimal tissue and use of plurip-
otent stem cells and LCLs were been approved by the Institutional
Animal Ethics Committee, Institutional Biosafety Committee,
and by the Institutional Committee for Stem Cell Research and
Therapy.
Isolation and Characterization of Lipid Bodies from
HuES7 Stem Cells
Lipid bodes were isolated using a modified density gradient
ultracentrifugation method (Bulankina, 2003). Three hundredFigure 7. The Blue Fluorescence in Lipid Bodies Arises from Reti
(A) Lipid bodies isolated from HuES7 cells using sucrose gradient cen
(B) Chloroform: methanol extracts of fluorescent lipid bodies and reti
traces of individual samples were normalized to their maximum emis
(C) C18 reverse-phase HPLC of the CHCl3:MeOH extract and retinyl sta
have identical retention times.
(D) Reverse-phase HPLC analysis of CHCl3:MeOH extracts of FBS and se
retinol.
(E) Lipid bodies in HuES7 cells cultured in standard HuESC media sup
increase in blue fluorescence.
(F) HuES7 cells cultured in chemically defined E8 media (lacks reti
fluorescence with time and regain blue fluorescent lipid bodies in 48
Data are from three independent biological replicates; error bars indi
Stecolonies were scraped and resuspended in 2 ml of 2 M sucrose
solution in 10 mM Tris-HCl, and 1 mM EDTA buffer pH 7.4.
The cell suspension was vortexed four times for 30 s separated
by 2 min on ice and then passed four times through a 26G nee-
dle. Two milliliters each of 0.27 M and 0.135 M sucrose in Tris-
EDTA buffer was layered sequentially onto the cell suspension
in clear ultracentrifuge tubes (Beckman, part no. 344060) and
centrifuged at 150,000 3 g in a Beckman SW 40 Ti rotor for
1 hr and allowed to decelerate without braking. The topmost
layer containing the lipid bodies was collected and stored
at 20C until it was used.Staining of Lipid Bodies in Mouse Embryos at 3.5 dpc
and 6.5 dpc and Generation of Mouse EpiSC-like Cells
The preimplantation (3.5 dpc) and postimplantation (6.5 dpc)
embryos were isolated from CF1 mice using the method of
Shea and Geijsen (2007). The embryos were fixed with 4% para-
formaldehyde, stained with BODIPY 493/503 (Life Technologies;
D-3922) and imaged for green and blue fluorescence. Mouse
EpiSC-like cells were derived from 6.5 dpc embryos using a previ-
ously described protocol (Najm et al., 2011). Flattened-out
colonies were observed by 24–48 hr. The colonies were mechan-
ically dissected into small pieces and propagated once every
3–4 days. The colony morphology and presence of lipid body-
associated blue fluorescence were observed and evaluated at
each passage.In Vitro Conversion of Pluripotent StemCells between
Naive and Primed or Epiblast-like States
To convert mESCs to EpiSC state, i.e., naive to primed state, mES-
R1 and D3 cells were grown in HuESC medium with 10 ng/ml of
human Activin (Peprotech; 20-14) and 10 ng/ml bFGF on dishes
coated with 0.1% gelatin (300 Bloom; Sigma-Aldrich; G3500) in
13 PBS. The medium was replaced daily. The cells were closely
monitored for change in morphology and for the appearance of
lipid bodies along with the associated fluorescence characteristics.
For conversion of HuES7 cells to the naive mESC-like state,
primed state cells were grown on mitotically inactivated MEF in
media with the following composition: 48 ml DMEM/F12
(Invitrogen; 11320), 48 ml Neurobasal (Invitrogen; 21103), 1 ml
N2 supplement (Invitrogen; 17502048), 2 ml B27 supplementnoids Obtained from Sera or Serum Replacement Components
trifugation retain blue fluorescence and stain positive for BODIPY.
nyl palmitate have identical fluorescence spectra. The fluorescence
sion values.
ndards shows the major peak of the extract and retinyl palmitate to
rum-free commercially available ESC-grade media shows presence of
plemented with retinol and retinyl palmitate show dose-dependent
nol) show a steep decrease in lipid bodies (red arrows) and blue
hr when E8 is supplemented with retinol.
cate the SD. See also Figure S4.
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Retinoid Fluorescence in Pluripotent Stem Cells(Invitrogen; 17504044), 2 mg recombinant human LIF (Pepro-
tech; 300-05), 1 mM glutamine, 1% nonessential amino acids,
0.1 mM b-mercaptoethanol, penicillin-streptomycin, 5 mg/ml
BSA (Sigma; A9647), and small molecule inhibitors at the final
concentrations mentioned here: PD0325901 (1 mM; Tocris Bio-
science; 4192), CHIR99021 (3 mM; Tocris Bioscience; 4423), and
forskolin (10 mM; Tocris Bioscience; 1099) modified from an
earlier protocol (Hanna et al., 2010). The medium was changed
daily and colony morphology, disappearance of lipid bodies,
and change in fluorescence were monitored. The HuES7 cells
and the primed to naive converting cells were propagated up to
three passages by trypsinization, and at each passage, cells were
harvested for RNA isolation.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experi-
mental Procedures and four figures and can be found with
this article online at http://dx.doi.org/10.1016/j.stemcr.2014.
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